Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types

Dermatological & Miscellaneous Wound Types

Clinical wound specialists frequently encounter complex cutaneous ulcers resulting from specialized systemic disease processes, environmental exposures, or adverse iatrogenic events. These unique etiologies include diabetic neuropathic deformities, sickle cell leg ulcerations, radiation-induced soft tissue necrosis, and vesicant drug extravasations. Successful management demands an understanding of their underlying pathophysiology, anatomical distribution, pharmacological antidotes, and advanced interventional modalities. This section covers key dermatological and miscellaneous wound etiologies tested on the ABWM CWS examination.

---

1. Neuropathic Ulcers & Charcot Foot Deformity

Neuropathic ulcerations arise secondary to peripheral neuropathy, most commonly driven by diabetes mellitus. The triad of sensory, motor, and autonomic neuropathy creates the structural and functional environment for tissue destruction.

• Loss of Protective Sensation (LOPS): Evaluated using the 10-gram Semmes-Weinstein monofilament test. Patients with LOPS cannot perceive repetitive mechanical trauma, friction, or focal pressure, leading to painless tissue injury.
• Motor Neuropathy: Atrophy of intrinsic foot musculature leads to muscle imbalances, causing digital clawing, hammertoes, and prominent metatarsal heads.
• Autonomic Neuropathy: Loss of sweat gland innervation (anhidrosis) causes dry, fissured skin prone to cracking and bacterial entry, along with arteriovenous shunting that elevates bone blood flow.

Charcot Neuroarthropathy (Charcot Foot)

Charcot neuroarthropathy is a non-infectious, progressive destructive joint process affecting individuals with advanced peripheral neuropathy. Repetitive microtrauma to a insensate foot triggers an un-regulated inflammatory cascade, leading to osteoclast activation, periarticular bone resorption, joint dislocation, and structural collapse.

1. Acute Phase: Characterized by localized erythema, marked edema, and profound skin warming (affected foot temperature is elevated > 2°C compared to the contralateral foot). The acute Charcot foot is frequently misdiagnosed as cellulitis or osteomyelitis. However, elevation of the limb in acute Charcot rapidly reduces erythema and edema, whereas infection markers remain unchanged.
2. Chronic Phase (Deformity): Collapse of the tarsometatarsal (Lisfranc) or midtarsal joints leads to the classic "rocker-bottom" foot deformity. The downward displacement of the cuboid and navicular bones creates prominent plantar bony prominences vulnerable to pressure necrosis.

Off-Loading & Pressure Redistribution Modalities

The primary therapeutic intervention for neuropathic plantar ulcers and acute Charcot neuroarthropathy is aggressive pressure off-loading:

• Total Contact Casting (TCC): The gold standard for off-loading neuropathic plantar ulcers and stabilizing acute Charcot foot. TCC molds precisely to the lower leg and foot, distributing weight-bearing forces across the entire plantar surface and calf, reducing focal peak pressure over metatarsal heads by up to 84%.
• Removable Cast Walkers (RCW) & Custom Orthotics: Utilized once the acute inflammatory phase resolves or for patients unable to tolerate non-removable TCC.

---

2. Sickle Cell Leg Ulcers

Sickle cell leg ulcers represent a chronic cutaneous manifestation of sickle cell disease (HbSS genotype). Ulcerations affect 10% to 20% of adult sickle cell patients and are associated with severe morbidity and high recurrence rates (> 70%).

Pathophysiology

The etiology is multi-factorial, driven by chronic intravascular hemolysis:

1. Microvascular Vaso-Occlusion: Deoxygenated mutant hemoglobin S (HbS) polymerizes, forming rigid, sickled red blood cells that occlude dermal capillaries and microvessels, leading to severe localized ischemia.
2. Nitric Oxide Scavenging: Free hemoglobin released during intravascular hemolysis scavenges endothelium-derived nitric oxide (NO). NO depletion induces systemic vasoconstriction, endothelial dysfunction, and platelet activation.
3. Tissue Hypoxia: Chronic severe anemia coupled with localized microvascular thrombosis creates chronic tissue hypoxia.

Clinical Presentation & Distribution

• Anatomical Location: Characteristically located over areas with thin subcutaneous fat and high skin tension, specifically the medial and lateral malleoli of the ankles.
• Wound Appearance: Small, shallow, or punched-out ulcerations with raised margins, smooth wound beds containing yellow fibrotic slough or pale granulation tissue, and surrounding hyperpigmented, indurated skin.
• Pain Profile: Exceptionally painful out of proportion to physical size, severely disrupting sleep and daily functioning.

Comprehensive Management

• Vascular Assessment: Before applying compression therapy, arterial perfusion must be verified via Ankle-Brachial Index (ABI). Compression (20–30 mmHg) is safe ONLY if ABI >= 0.8.
• Systemic Optimization: Optimization of sickle cell management via systemic hydration, hydroxyurea therapy, and exchange blood transfusions to lower circulating HbS levels (< 30%).
• Topical & Support Care: Moisture-retentive dressings, systemic analgesics, and strict avoidance of local vasoconstrictive triggers (e.g., ice application or cold exposure).

---

3. Cutaneous Radiation Dermatitis & Late Radiation Necrosis

Therapeutic ionizing radiation utilized in oncology damages normal cutaneous tissue within the radiation field, producing acute and chronic cutaneous injuries.

Pathophysiology & Radiation Tissue Damage

Ionizing radiation generates reactive oxygen species (ROS) that break double-stranded DNA and damage microvascular endothelial cells. The hallmarks of radiation-induced tissue damage include:

• Obliterative Endarteritis: Progressive inflammation and thrombosis of small arteries and capillaries within the irradiated field, resulting in microvascular obliteration.
• Stromal Fibrosis & Hypoxia: Replacement of normal dermis with dense, hypocellular collagenous scar tissue. The resulting tissue bed is classically characterized by the Marx Triad: Hypovascular, Hypocellular, and Hypoxic.
• Timeline: Acute radiation dermatitis (erythema, dry/moist desquamation) occurs within weeks of therapy. Conversely, Late Radiation-Induced Tissue Necrosis (radionecrosis) can present months to decades following radiotherapy, often triggered by minor trauma or infection in the hypoxic tissue.

Indications for Hyperbaric Oxygen Therapy (HBOT)

Hyperbaric Oxygen Therapy (100% oxygen inhaled at 2.0 to 2.5 atmospheres absolute) is an established, evidence-based therapy for late radiation tissue injury (Marx Protocol):

• Mechanism of Action: HBOT dramatically elevates plasma-dissolved oxygen concentrations, creating a steep tissue oxygen gradient. This gradient stimulates angiogenesis (capillary sprouting), activates macrophage-mediated wound debridement, and promotes fibroblast proliferation and collagen synthesis within hypocellular, irradiated tissue.
• Clinical Application: Administered in 30 to 40 daily sessions (hyperbaric profiles) to heal radiation necrosis or pre-operatively prior to surgical debridement/grafting in irradiated fields to prevent surgical wound breakdown.

---

4. Extravasation Injuries & Pharmacological Antidotes

Extravasation is defined as the inadvertent leakage of vesicant intravenous medications or fluids from a vascular access device into surrounding subcutaneous tissue, resulting in tissue destruction, blistering, and severe necrosis.

Emergency Extravasation Management Protocol

Upon suspicion of vesicant extravasation, the clinician must execute the following protocol immediately:

1. Stop Infusion Immediately: Discontinue IV administration; DO NOT immediately remove the IV cannula.
2. Aspirate Residual Drug: Attach a syringe to the cannula hub and aspirate as much remaining vesicant drug from the catheter lumen as possible.
3. Administer Local Antidote: If a specific local antidote (e.g., phentolamine or hyaluronidase) is indicated, instill the medication directly through the existing IV catheter before removal, then remove the catheter.
4. Infiltrate Antidote Subcutaneously: For vasopressor extravasation (norepinephrine), infiltrate Phentolamine (alpha-1 blocker) subcutaneously throughout the affected area using a fine needle in a ring pattern to reverse microvascular vasoconstriction.
5. Elevate Extremity & Apply Thermal Compresses: Elevate the affected limb above heart level for 48 hours to reduce edema. Apply thermal compresses according to the vesicant class (cold for vasopressors and anthracyclines; warm for vinca alkaloids).

---

Pediatric Wound Considerations (Domain 4)

Pediatric issues are a distinct ABWM etiology topic. Children are not small adults:

• Skin structure: thinner epidermis, higher BSA-to-mass ratio, and relatively larger head/neck surface area—use Lund-Browder (not adult Rule of Nines alone) for burn TBSA.
• Healing tempo: generally faster granulation and epithelialization when perfusion and nutrition are adequate, but scar hypertrophy and contracture risk can be high across joints.
• Product / dressing safety: avoid potentially toxic topicals in neonates/infants (e.g., caution with povidone-iodine absorption, silver products per age/labeling, and occlusive wraps that impair thermoregulation). Prefer atraumatic adhesives and silicone borders to prevent medical adhesive-related skin injury (MARSI).
• Pain and adherence: procedural pain, fear, and caregiver technique errors commonly stall progress—plan age-appropriate analgesia, distraction, and caregiver teaching.
• Etiology mix: accidental trauma, burns, epidermolysis bullosa and other genetic dermatoses, pressure injuries in critically ill infants, and surgical wounds require etiology-specific plans rather than adult DFU/VLU defaults.
• Growth plates: avoid aggressive therapeutic ultrasound over open epiphyseal plates; coordinate with pediatric specialists for complex reconstruction.

Exam vignettes that mention neonates, toddlers, or school-age children should trigger pediatric-specific TBSA tools, adhesive trauma prevention, and toxin-avoidance reasoning rather than adult compression/off-loading scripts alone.